The application patent of the anti-flu drug zanamivir expires in the second half year(news source), the enterprises focused on imitation medicines will have one more selection.
Sialic acid as the main raw material of producing zanamivir, its market must get better. CASOV will expand production capacity to meet the potential large orders.